Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Lifestyle Intervention vs Drugs in Overweight PCOS with IGT
NCT02446834Completed
- Sponsor
- Renji Hospital
- Start
- Apr 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of metformin and acarbose in polycystic ovary syndrome (PCOS) and impaired glucose tolerance (IGT), sponsored by Renji Hospital. Started Apr 2015; status: completed.
02
Drugs
metforminacarbose
03
Conditions
polycystic ovary syndrome (PCOS)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT02446834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446834.